The research aims to evaluate how lenvatinib affects liver function and its implications for prognosis.
Retrospective design analyzing liver function data
Inclusion criteria: minimum 2 months of treatment
Assessment of liver function tests pre- and post-treatment
Observed changes in liver function after lenvatinib treatment
Reported potential prognostic significance of these changes
Abstract
The limitations of this study include its retrospective design and the potential for selection bias arising from the requirement for at least 2 months of treatment.